A few weeks ago the DEA allowed a California university to import cannabis from Canada for medical marijuana research. And now members of Congress are not happy.
15 members of Congress wrote a letter to the DEA and Attorney General Jeff Sessions to voice their displeasure about the policy. The members argued that there are plenty of American cannabis producers who could've fulfilled the order for this research study, and questioned why the DEA thought they had to go to Canada.
The lawmakers also pointed out how this policy contradicts President Donald Trump's "Buy American" executive order that is supposed to give preference to American companies for contracts such as this.
This incident once again highlights the disconnect between members of Congress and the Department of Justice regarding marijuana. The DOJ's policies are often criticized as being confusing and there seems to be no rhyme or reason behind any of their decisions. Why won't they approve new contractors to grow marijuana for research purposes, but will ok a California University to import marijuana for research?
The combination of Canada legalizing marijuana and the midterms approaching is putting marijuana into the spotlight. The only question is how will the federal government handle it.